Richard Pilot

Statistics

Publications

Citations

598

H-Index

Active since

2008

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Richard Pilot is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacotherapy, and serious adverse events.

Publications per year

2008–2024

Publications

The effects of imatinib on pregnancy outcome

Seonaid Pye, Jörge E. Cortes, Patricia Ault et al. · Blood · 2008 · 392 citations

Medicine, Obstetrics, Pharmacotherapy +8

Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)

David Goldstein, Daniel D. Von Hoff, Malcolm J. Moore et al. · European Journal of Cancer · 2015 · 52 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial

Matteo Della Porta, Guillermo Garcia‐Manero, Valeria Santini et al. · The Lancet Haematology · 2024 · 48 citations

Medicine, Hematology, Pharmacotherapy +11

Electrocardiographic effects of class 1 selective histone deacetylase inhibitor romidepsin

Philip T. Sager, Barbara Balser, Julie Wolfson et al. · Cancer Medicine · 2015 · 40 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes

Vera Hirsh, Amy Ko, Richard Pilot et al. · Clinical Lung Cancer · 2016 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 6